These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8635854)

  • 1. Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease.
    Shuja S; Murnane MJ
    Int J Cancer; 1996 May; 66(4):420-6. PubMed ID: 8635854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin B activity and protein levels in thyroid carcinoma, Graves' disease, and multinodular goiters.
    Shuja S; Cai J; Iacobuzio-Donahue C; Zacks J; Beazley RM; Kasznica JM; O'Hara CJ; Heimann R; Murnane MJ
    Thyroid; 1999 Jun; 9(6):569-77. PubMed ID: 10411119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on cathepsin B activity in human thyroid tumors.
    Kusunoki T; Nishida S; Nakano T; Funasaka K; Kimoto S; Murata K; Tomura T
    Auris Nasus Larynx; 1995; 22(1):43-8. PubMed ID: 7677635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of inducible nitric oxide synthase in thyroid neoplasms: immunohistochemical and molecular analysis.
    Choe W; Kim S; Hwang TS; Lee SS
    Pathol Int; 2003 Jul; 53(7):434-9. PubMed ID: 12828608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue.
    Campo E; Merino MJ; Liotta L; Neumann R; Stetler-Stevenson W
    Hum Pathol; 1992 Dec; 23(12):1395-401. PubMed ID: 1468777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in active cysteine cathepsins in lysosomes from tissues thyroid papillary carcinomas with various biological characteristics].
    Kalinichenko OV; Myshunina TM; Tron'ko MD
    Fiziol Zh (1994); 2013; 59(5):11-9. PubMed ID: 24400560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of motilin and its precursor mRNA in normal parenchyma, benign and malignant tumors of human thyroid].
    Xu L; Zhong F; Guo FF; Zhao WJ; Sun XR; Wei XF
    Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):243-9. PubMed ID: 18844033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas.
    Shuja S; Sheahan K; Murnane MJ
    Int J Cancer; 1991 Sep; 49(3):341-6. PubMed ID: 1917131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NITRIC OXIDE SYNTHASE ACTIVITY AND ITS CONCENTRATION IN THE TISSUES OF HUMAN THYROID CARCINOMAS.
    Kalinichenko OV; Myshunina TM; Tron’ko MD
    Fiziol Zh (1994); 2016; 62(3):9-19. PubMed ID: 29569867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity in benign and malignant human thyroid tissues.
    Cheng AJ; Lin JD; Chang T; Wang TC
    Br J Cancer; 1998 Jun; 77(12):2177-80. PubMed ID: 9649130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues.
    Ulisse S; Delcros JG; Baldini E; Toller M; Curcio F; Giacomelli L; Prigent C; Ambesi-Impiombato FS; D'Armiento M; Arlot-Bonnemains Y
    Int J Cancer; 2006 Jul; 119(2):275-82. PubMed ID: 16477625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of type I and IV collagenase activity in human thyroid diseases].
    Nakano T; Kusunoki T; Funasaka K; Murata K; Nishida S; tomura T
    Nihon Jibiinkoka Gakkai Kaiho; 1995 Jun; 98(6):937-41. PubMed ID: 7629646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.
    Weyemi U; Caillou B; Talbot M; Ameziane-El-Hassani R; Lacroix L; Lagent-Chevallier O; Al Ghuzlan A; Roos D; Bidart JM; Virion A; Schlumberger M; Dupuy C
    Endocr Relat Cancer; 2010 Mar; 17(1):27-37. PubMed ID: 19779036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroglobulin processing by thyroidal proteases. Major sites of cleavage by cathepsins B, D, and L.
    Dunn AD; Crutchfield HE; Dunn JT
    J Biol Chem; 1991 Oct; 266(30):20198-204. PubMed ID: 1939080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.
    Friedrich B; Jung K; Lein M; Türk I; Rudolph B; Hampel G; Schnorr D; Loening SA
    Eur J Cancer; 1999 Jan; 35(1):138-44. PubMed ID: 10211102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of proliferation, differentiation and dedifferentiation factors on the expression of the lysosomal cysteine proteinase cathepsin L (CL) in thyroid cancer cell lines.
    Plehn A; Günther D; Aurich H; Hoang-Vu C; Weber E
    Adv Exp Med Biol; 2000; 477():487-95. PubMed ID: 10849775
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines.
    Maciewicz RA; Wardale RJ; Etherington DJ; Paraskeva C
    Int J Cancer; 1989 Mar; 43(3):478-86. PubMed ID: 2647640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.